Effect of a traditional Japanese herbal medicine, Hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons

International Immunopharmacology

Volumn 4, Issue 2, 2004, Pages 317-324

  Kuroiwa, Ataru ^a   Liou, Shin'yu ^a   Yan, Hong ^a   Eshita, Akihiko ^b   Naitoh, Seiko ^c   Nagayama, Ariaki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Eshita Naika Clinic   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Hochu ekki to (HOT); IFN ; Immunosenescence; NK activity

Indexed keywords

ANCHU SAN; BU ZHONG YI QI TANG; CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HERBACEOUS AGENT; INTERLEUKIN 2 RECEPTOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; B LYMPHOCYTE; CELL STRAIN K 562; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HERBAL MEDICINE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOMODULATION; IMMUNOSTIMULATION; LEUKOCYTE; MALE; MEDICINAL PLANT; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRADITIONAL MEDICINE;

ADMINISTRATION, ORAL; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ASIAN CONTINENTAL ANCESTRY GROUP; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERFERON TYPE II; KILLER CELLS, NATURAL; MALE; T-LYMPHOCYTE SUBSETS;

EID: 1542332652     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.12.004     Document Type: Article

References (39)

1. Makinodan T., Kay M.M.B. Age influence on the immune system. Adv. Immunol. 29:1980;287-330.
2. Miller R.A. Immune system. Masoro E. Handbook of Physiology. Section 11. Aging. 1995;555-590 Oxford Univ. Press, New York.
3. Hirokawa K., Utsuyama M., Kasai M. Role of the thymus in aging of the immune system. Goldstein A.L. Biomedical Advances in Aging. 1990;375-390 Plenum Press, New York.
4. Ginaldi L., De-Martinis M., D'Ostilio A., Marini L., Loreto M.F.et al. The immune system in the elderly: I. Specific humoral immunity. Immunol. Res. 20:1999;101-108.
5. Hossain M.S., Takimoto H., Hamano S., Yoshida H., Ninomiya T.et al. Protective effects of Hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection. Immunopharmacology. 41:1999;169-181.
6. Yamaoka Y., Kawakita T., Kishihara K., Nomoto K. Effect of traditional Chinese medicine, Bu-zhong-yi-qi-tang, on the protection against an oral infection with Listeria monocytogenes. Immunopharmacology. 39:1998;215-223.
7. Li T., Harada M., Tamada K., Abe K., Tada H.et al. The restoration of the antitumor T cell response from stress induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41: Bu-zhong-yi-qi-tang). Immunopharmacology. 43:1999;11-21.
8. Iwama H., Amagaya S., Ogihara Y. Effects of five kampohozais on the mitogenic activity of lipopolysaccharide, concanavalin A, phorbol myristate acetate and phytohemagglutinin in vivo. J. Ethnopharmacol. 18:1986;193-204.
9. Utsuyama M., Seidler H., Kitagawa M., Hirokawa K. Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice. Mech. Ageing Dev. 122:2001;341-352.
10. Ishimitsu R., Nishimura H., Kawauchi H., Kawakita T., Yoshikai Y. Dichotomous effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang on allergic asthma in mice. Int. Immunopharmacol. 1:2001;857-865.
11. Yamaoka Y., Kawakita T., Nomoto K. Protective effect of a traditional Japanese medicine Hochu-ekki-to (Chinese name: Bu-zhong-yi-qi-tang) on the susceptibility against Listeria momocytogenes in infant mice. Int. Immunopharmacol. 1:2001;1669-1677.
12. Suzuki T., Takano I., Nagai F., Fujitani T., Ushiyama K.et al. Suppressive effects of Hochu-ekki-to, a traditional Chinese medicine, on IgE production and histamine release in mice immunized with ovalbumin. Biol. Pharm. Bull. 22:1999;1180-1184.
13. Kaneko M., Kawakita T., Yamaoka Y., Nomoto K. Development of the susceptibility to oral tolerance induction in infant mice administered a herbal drug, Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang). Int. Immunopharmacol. 1:2001;219-227.
14. Ohono S. Effects of a traditional Chinese medicine Hochu-ekki-to on natural killer activity. Allergy (Japanese). 37:1988;107-114.
15. Yan H., Kuroiwa A., Tanaka H., Shindo M., Kiyonaga A.et al. Effect of moderate exercise on immune senescence in men. Eur. J. Appl. Physiol. 86:2001;105-111.
16. Solana R., Pawelec G. Molecular and cellular basis of immunosenescence. Mech. Ageing Dev. 102:1998;115-129.
17. Walker D., Gauchat J.F., De Weck A.L., Stadler B.M. Analysis of leukocyte markers in elderly individuals. Aging Immunol. Infect. Dis. 2:1990;31-43.
18. + T cell subsets in human peripheral blood. Mech. Ageing Dev. 63:1992;57-68.
19. Boersma W.J.A., Steinmeier F.A., Haaijman J.J. Age-related changes in the relative number of Thy-1 and Lyt-2 bearing peripheral blood lymphocytes in mice: a longitudinal approach. Cell Immunol. 93:1985;417-430.
20. Masoro E.J. Food restriction in rodents: an evaluation of its role in the study of aging. J. Gerontol. 43:1988;B59-B64.
21. Lustyik G., O'Leary J.J. Aging and the mobilization of intracellular calcium by phytohemagglutinin in human T cells. J. Gerontol. 44:1989;B30-B36.
22. Armanini D., Karbowiak I., Scali M., Orlandini E., Zampollo V.et al. Corticosteroid receptors and lymphocyte subsets in mononuclear leukocytes in aging. Am. J. Physiol. 262:1992;E464-E466.
23. Shinkai S., Kohno H., Kimura K., Komura T., Asai H.et al. Physical activity and immune senescence in men. Med. Sci. Sports Exerc. 27:1995;1516-1526.
24. Hirokawa K., Makinodan T. Thymic involution: effect on T cell differentiation. J. Immunol. 114:1975;1659-1664.
25. Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G.et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 82:1993;2767-2773.
26. + lymphocytes and relationship to serum TNF-α, IFN-γ, and sIL2R levels in aging. Exp. Gerontol. 34:1999;79-93.
27. Jaruga E., Skierski J., Rdziszewska E., Sikora E. Proliferation and apoptosis of human T cells during replicative senescence - a critical approach. Acta Biochim. Pol. 47:2000;293-300.
28. Pawelec G., Solana R., Remarque E., Mariani E. Impact of aging on innate immunity. J. Leukoc. Biol. 64:1998;703-712.
29. + (CD16) large granular lymphocytes and decreased NK activity during human aging. Clin. Exp. Immunol. 68:1987;340-347.
30. Vitale M., Zamai L., Neri L.M., Galanzi A., Facchini A.et al. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell Immunol. 145:1992;1-10.
31. Borrego, F., Alonso, C., Galiani, M., Carracedo, J., Ramirez, R., et al. NK phenotypic markers and IL-2 response in NK cells from elderly people. Exp Gerontol 34:253-265
32. Solana R., Mariani E. NK and NK/T cells in human senescence. Vaccine. 18:2000;1613-1620.
33. + cell reactivity: clonal analysis. Clin. Exp. Immunol. 81:1990;479-484.
34. Ellis T.M., McKenzie R.S., Simms P.E., Helfrich B.A., Fisher R.I. Induction of human lymphokine-activated killer cells by IFN-α and IFN-γ J. Immunol. 143:1989;4282-4287.
35. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
36. Kutza J., Murasko D.M. Effect of aging on natural killer cell activity and activation by interleukin-2 and IFN-α Cell Immunol. 155:1994;195-204.
37. Chan S.H., Perussia B., Gupta J.W., Kobayashi M., Pospisil M.et al. Induction of interferon-gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
38. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
39. Mariani E., Mariani A.R., Meneghetti A., Tarozzi A., Cocco L.et al. Age-dependent decreases of NK cell phosphoinisitide turnover during spontaneous but not Fc mediated cytolytic activity. Int. Immunol. 10:1998;981-989.